Norina Mohd Nordin, MD
Vascular Surgery · Leesburg, FLNPI 1356584973
Payments from drug & device makers
What this record shows
This record is dominated by other: $17,417 of the $22,549 with a category attached, or 77.2%. Angiodynamics, Inc. accounts for 77.2% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $20,448, more than ten times the $54 reported in 2019.
Across 78 payments — averaging $289.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$17K
- Penumbra, Inc.$2K
- W. L. Gore & Associates, Inc.$1K
- Medtronic$729
- Boston Scientific$243
- Cvrx, Inc.$110
- plus $173 from 5 others
What the payments were for
- Travel & lodging$1,8268%
- Food & beverage$3,30715%
- Other$17,41777%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $17,417 |
| Penumbra, Inc. | 42 | $2,476 |
| W. L. Gore & Associates, Inc. | 11 | $1,402 |
| Medtronic | 12 | $729 |
| Boston Scientific | 2 | $243 |
| Cvrx, Inc. | 2 | $110 |
| Johnson & Johnson | 3 | $67 |
| Endologix LLC | 1 | $44 |
| Venclose Inc. | 1 | $28 |
| Silk Road Medical, Inc. | 1 | $22 |
| Lemaitre Vascular, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,549 in reported general payments places this provider in the 80th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 79 | $787 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Leesburg
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
- Joseph RicottaDelray Beach$156K
- Murray ShamesTampa$144K
- K Dean ArnaoutakisTampa$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.